Physician practicesPhysician practices
You already know the importance of regular screening for all of your patients. Simtomax® can help streamline this process for your practice by eliminating the inconvenience of dealing with an outside laboratory and following up with patients.
Point-of-care testing yields immediate results, enabling testing and follow-up in a single patient visit.
Here's how the Simtomax® can benefit your practice:
Minimize invasiveness of the procedureSimtomax® works with a very small amount of blood (25µl), sampled from a finger pin-prick. This is a huge advantage over a traditional venous blood sample - especially if your patient is a child.
And if you are undertaking a venous blood sample anyway, Simtomax® works equally with serum or plasma (EDTA and heparinated) with an adjusted volume of 20µl.
No outside laboratoryWith a point-of-care test, you do not need anymore to deal with the hassle of shipping the samples to an external laboratory. This means less paperwork, less errors and more time with your patient.
Get immediate resultsSimtomax® delivers lab-accurate results in just 10 minutes. This allows you to handle testing and follow-up during the same patient visit.
Easy interpretation of resultsSimtomax® results are visually-read, leaving no place for wrong interpretation. The threshold of detection has been carefully designed to show a positive result at the cut-off values of the equivalent laboratory kits.
Reduce time-to-diagnosisTime-to-diagnosis is extremely long for Celiac Disease: many studies report delays longer than 6 year [1-6]. It has often been suggested that the long duration of symptoms is mostly because of a physician delay in reaching the diagnosis rather than a patient delay in seeking medical attention. This can be different with a point-of-care test that allows you to screen-out Celiac Disease very quickly.
Additional practice incomeProvides potential for additional billing revenue without additional staff. And Simtomax® requires no specific equipment - no investment.
 Green PHR, Stavropoulos SN, Panagi SG, et al. Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 2001; 96: 126-31.
 Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006; 131: 1981-2002.
 Lankisch PG, Martinez Schramm A, Petersen F, Droge M, Lehnick D, Lembcke B. Diagnostic intervals for recognizing celiac disease. Z Gastroenterol 1996; 34: 473-7.
 Dickey W, McConnell JB. How many hospital visits does it take before celiac sprue is diagnosed? J Clin Gastroenterol 1996; 23: 21-3.
 Schramm AM, Lankisch PG. Long delay before celiac disease is recognized. J Clin Gastroenterol 1997; 25: 404-5.
Sanders DS, Hurlstone DP, Stokes RO, et al. Changing face of adult coeliac disease: experience of a single university hospital in South Yorkshire. Postgrad Med J 2002; 78: 31-3.